Dr. David M. Schultz, M.D.
Pain Medicine (Pain Medicine (Anesthesiology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 306
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: University of Minnesota Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pain Medicine (Anesthesiology) Physician primary
MN license 28811 -
Interventional Pain Medicine Physician
MN license 28811
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Orthopaedic and Fracture Clinic, P.a. (33 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 306
- Services billed
- 508
- Patients’ average age
- 65
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 609 | 426 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 148 | 112 |
| Compounded drug, not otherwise classified | 147 | 112 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 62 | 61 |
| New patient office or other outpatient visit, 45-59 minutes | 55 | 55 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 52 | 40 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | 16 |
| Established patient office or other outpatient visit, 20-29 minutes | 12 | 12 |
| Injection of substance into lower spine canal using imaging guidance | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Cephalexin Other prescribers in Edina, MN | 29 |
| Mupirocin Other prescribers in Edina, MN | 27 |
| Oxycodone Hcl Other prescribers in Edina, MN | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $43.46 in total to this clinician.
| Biotronik Nro, Inc. | $27.74 |
|---|---|
| Collegium Pharmaceutical, Inc. | $15.72 |
| Food and Beverage | $43.46 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $940,599 in research payments for these studies, mostly to the institutions running them.
- PSR-TDD
Medtronic, Inc. - PSR-PSTM
Medtronic, Inc. - NCT03876054--Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.